Review Highlights Gaps Between Clinical Guidelines and Real-World Atopic Dermatitis Care
A narrative review examining the full patient journey in atopic dermatitis (AD) underscores persistent barriers that limit optimal disease control despite advances in therapy. The authors emphasize that real-world experiences often diverge from guideline-directed care due to delays in diagnosis, misinformation, fragmented care, and psychological burden.
AD is described as a “chronic, relapsing inflammatory skin disease that significantly impacts the physical, psychological, and social well-being of patients.” While structured treatment pathways exist, the review notes that patients frequently encounter medical, emotional, and financial challenges that impair adherence and reduce quality of life.
Key inflection points in the patient journey include pre-diagnosis awareness, access to specialist referral, and transition to advanced therapies when needed. Delayed recognition by primary care providers and inconsistent referral patterns may prolong uncontrolled disease. The authors stress the importance of early identification and coordinated care, highlighting that “understanding the patient journey is essential for developing more inclusive and effective care models.”
Even as new topical agents, systemic therapies, and biologics expand treatment options, barriers remain. Fear of topical corticosteroids, cost constraints, and limited access to advanced therapies continue to influence patient decision-making and adherence. Emotional distress and stigma further complicate management.
The review advocates for a proactive, patient-centered approach that includes clear communication, structured education, and integration of teledermatology where appropriate. Enhanced care coordination between primary care, dermatology, and allied health professionals is also recommended to improve continuity.
Reference
Sharma T, Balasubramanian A, Dhoot D, Patil S, Barkate H. The atopic dermatitis patient journey: from awareness to advanced care. Cureus. 2026;18(1):e102538. doi:10.7759/cureus.102538
